Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. Genetique de la Nephropathie Diabetique (GENEDIAB) study group

Journal of Clinical Investigation

Volumn 99, Issue 7, 1997, Pages 1585-1595

  Marre, Michel ^a,m   Jeunemaitre, Xavier ^b   Gallois, Yves ^a   Rodier, Michel ^c   Chatellier, Gilles ^b   Sert, Caroline ^d   Dusselier, Laurent ^e   Kahal, Zoubida ^f   Chaillous, Lucy ^g   Halimi, Serge ^h   Muller, Anne ⁱ   Sackmann, Henry ^j   Bauduceau, Bernard ^k   Bled, Françoise ^a   Passa, Philippe ^l   Alhenc Gelas, François ^m  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL BROUSSAIS   (France)

^c NÎMES UNIVERSITY HOSPITAL   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

^f University Hospital   (France)

^g NANTES UNIVERSITY HOSPITAL   (France)

^h GRENOBLE UNIVERSITY HOSPITAL   (France)

ⁱ POITIERS UNIVERSITY HOSPITAL   (France)

^j CHU RANGUEIL   (France)

^k SERVICE D ENDOCRINOLOGIE   (France)

^l SAINT LOUIS HOSPITAL   (France)

^m INSERM   (France)

more..

Author keywords

angiotensin I converting enzyme; angiotensinogen; diabetes mellitus; diabetic nephropathy; glomerular disease

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

EID: 0030951794     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119321     Document Type: Article

References (78)

1. Mogensen, C.E. 1994. Definition of diabetic renal disease in insulin-dependent diabetes mellitus based on renal function tests. In The Kidney and Hypertension in Diabetes Mellitus. C.E. Mogensen, editor. Kluwer Academic Publishers, Dordrecht, The Netherlands. 1-14.
2. Krolewski, A.J., J.H. Warram, L.I. Rand, and C.R. Kahn. 1987. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N. Engl. J. Med. 317:1390-1398.
3. Borch-Johnsen, K., and S. Kreiner. 1987. Proteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes. BMJ (Br. Med. J.). 294:1651-1654.
4. Mauer, M.S., M.W. Steffes, D.E.R. Sutherland, J.S. Najarian, A.F. Michael, and M. Brown. 1975. Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes. 24:250-255.
5. Pirart, J. 1977. Diabète et complications dégénératives. Présentation d'une étude prospective portant sur 4400 cas observés entre 1947 et 1973. Diabete Metab. 3:97-107, 173-182, 245-256.
6. The Diabetes Control and Complications Trial Reseach Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:977-986.
7. Seaquist, E.R., F.C. Goetz, S. Rich, and J. Barbosa. 1989. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N. Engl. J. Med. 320:1161-1165.
8. Pettit, D.J., M.F. Saad, P.H. Bennett, R.G. Nelson, and W.C. Knowler. 1990. Familial predisposition to renal disease in two generations of Pima Indians with 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 33:438-443.
9. Earle, K., J. Walker, C. Hill, and G.C. Viberti. 1992. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N. Engl. J. Med. 326:673-677.
10. Hostetter, T.H., J.L. Troy, and B.M. Brenner. 1981. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 19:410-415.
11. Marre, M., H. Leblanc, L. Suarez , T.T. Guyenne, J. Menard, and P. Passa. 1987. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. BMJ (Br. Med. J.). 294: 1448-1452.
12. Hall, J.E., A.C. Guyton, T.E. Ackson, T.G. Coleman, T.E. Lohmeier, and N.C. Tripoddo. 1977. Control of glomerular filtration rate by renin-angiotensin system. Am. J. Physiol. 233:F366-F372.
13. Cambien, F., F. Alhenc-Gelas, B. Herberth, J.L. Andre, R. Rakotovao, M.F. Gonzales, J. Allegrini, and C. Bloch. 1988. Familial ressemblance of plasma angiotensin converting enzyme level: the Nancy study. Am. J. Hum. Genet. 43:774-780.
14. Costerousse, O., J. Allegrini, M. Lopez, and F. Alhene-Gelas. 1993. Angiotensin I converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem. J. 290:33-40.
15. Jeunemaitre, X., F. Soubrier, Y. Kotelevtsev, R. Lifton, C. Williams, A. Charru, S. Hunt, P. Hopkins, R. Williams, J.M. Lalouel, et al. 1992. Molecular basis of human hypertension: role of angiotensinogen. Cell. 71:169-180.
16. Caulfield, M., P. Lavender, M. Farrall, P. Munroe, M. Lawson, P. Turner, and A.J.L. Clark. 1994. Linkage of the angiotensinogen gene to essential hypertension. N. Engl. J. Med. 330:1629-1633.
17. Rigat, B., C. Hubert, F. Alhene-Gelas, F. Cambien, P. Corvol, and F. Soubrier. 1990. An insertion deletion polymorphism in angiotensin I conversion enzyme gene accounting for half of the variance of serum enzyme levels. J. Clin. Invest. 86:1343-1346.
18. Cambien, F., O. Poirier, L. Lecerf, A. Evans, J.P. Cambou, D. Arveiler, G. Luc, J.M. Bard, L. Bara, S. Ricard, et al. 1992. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature (Lond.). 359:641-644.
19. Ruiz, J., H. Blanche, N. Cohen, G. Velho, F. Cambien, D. Cohen, P. Passa, and P. Froguel. 1994. Insertion/deletion polymorphism of the angiotensin converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA. 91: 3662-3665.
20. Nakai, K., C. Itoh, Y. Miura, K. Hotta, T. Musha, T. Itoh, T. Miyakawa, R. Iwasaki, and K. Hiramori. 1994. Deletion polymorphism of the angiotensin I converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 90:2199-2202.
21. Mattu, R.K., E.W.A. Needham, D.J. Galton, E. Frangos, A.J.L. Clark, and M. Caulfield. 1995. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the caerphilly heart study. Circulation. 91:270-274.
22. Badenhop, R.F., X.L. Wang, and D.E.L. Wilcken. 1995. Angiotensin converting enzyme genotype in children and coronary events in their grandparents. Circulation. 91:1655-1658.
23. Ludwig, E., P.S. Corneli, J.L. Anderson, H.W. Marshall, J.M. Lalouel, and R.H. Ward. 1995. Angiotensin converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 91:2120-2124.
24. Keavney, B.D., C.R.K. Dudley, I.M. Stratton, R.R. Holman, D.R. Matthews, P.J. Ratcliffe, and R.C. Turner. 1995. UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting-enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia. 38:948-952.
25. Bonnardeaux, A., E. Davies, X. Jeunemaitre, I. Fery, A. Charru, E. Clauser, L. Tiret, F. Cambien, P. Corvol, and F. Soubrier. 1994. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 24:63-69.
26. Marre, M., P. Bernadet, Y. Gallois, F. Savagner, T.T. Guyene, M. Hallab, F. Cambien, P. Passa, and F. Alhenc-Gelas. 1994. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes. 43:384-388.
27. Doria, A., J.H. Warram, and A.S. Krolewski. 1994. Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I converting enzyme gene. Diabetes. 43:690-695.
28. Fogarty, D.G., A.P. Maxwell, A. Hughes, N.C. Nevin, and C.C. Doherthy. 1994. A deletion polymorphism in the angiotensin-converting-enzyme gene is a risk factor for diabetic nephropathy. European Dialysis Transplantation Association (EDTA), proceedings of XXIst Congress. Abstract volume. 117.
29. Powrie, J.K., G.F. Watts, J.N. Ingham, N.A. Taub, P.J. Talmud, and K.M. Shaws. 1994. Role of glycæmic control in development of microalbuminuria in patients with insulin-dependent diabetes. BMJ (Br. Med. J.) 309:1608-1612.
30. Tarnow, L., F. Cambien, P. Rossing, F.S. Nielsen, B.V. Hansen, L. Lecerf, O. Poirier, S. Danilov, and H.H. Parving. 1995. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converving enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes. 44:489-494.
31. Schmidt, S., N. Schone, E. Ritz, and the Diabetic Nephropathy Study Group. 1995. Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int. 47:1176-1181.
32. Mizuiri, S., H. Hemmi, A. Inoue, H. Yoshikawa, M. Tanegashima, T. Fushimi, M. Ishigami, Y. Amagasaki, T. Ohara, H. Shimatake, and A. Hasegawa. 1995. Angiotensin-converting-enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron. 70:455-459.
33. Doi, Y., H. Yoshizumi, K. Lino, M. Yamamoto, K. Ichikawa, M. Iwase, and M. Fujishima. 1996. Association between a polymorphism in the angiotensin-converting-enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia. 39:97-102.
34. Dudley, C.R.K., B. Keavney, I.M. Stratton, R.C. Turner, and P.J. Ratcliffe. 1995. U.K. prospective diabetes study XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int. 48:1907-1911.
35. Marre, M., H. Leblanc, D. Bruel, M. Leroy, and P. Passa, 1986. Relations entre excrétion urinaire d'albumine et rétinopathic chez les diabétiques insulino-dépendants. Presse Med. 15:1621-1624.
36. WHO Expert Committee on Diabetes Mellitus. 1980. 2nd report. Geneva. 1980. (WHO technical report series No. 646).
37. Kohner, E.M. 1991. The lesions and natural history of diabetic retinopathy, chapter 58. In Textbook of Diabetes. J. Pickup and G. Williams, editors. Blackwell Scientific Publications, Oxford. 575-588.
38. Gallois, Y., S. Vol, E. Caces, B. Balkau, and the DESIR Study Group. 1996. Distribution of fasting serum insulin, measured by enzymoimmunoassay, in an unselected population of 4032 individuals, references values, according to age and sex. Diabetes Metab. 22:427-431.
39. Goldstein, D.E., R.R. Little, J.D. England, H.M. Wiedmeyer, and E.M. McKenzie. 1986. Methods for quantitating glycosylated hemoglobins: high-performance liquid chromatography and thiobarbituric acid colorimetry. In Methods in diabetes research. Vol. 2: Clinical methods. W.L. Clarke, J. Larner, and S.L. Pohl, editors. John Wiley & Sons, New York. 475-504.
40. Blackburn, H. 1969. Classification of the electrocardiogram for population studies: Minnesota code. J. Electrocardiol. 2:305-310.
41. Rigat, B., C. Hubert, P. Corvol, and F. Soubrier. 1992. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) dipeptidyl-carboxy peptidase. Nucleic Acids Res. 20:1433.
42. Shanmugam, V., K.W. Sell, and B.K. Saha. 1993. Mistyping ACE heterozygotes. PCR Methods Applications. 3:120-121.
43. Neels, H.M., M.E. Van Sande, and S.L. Scharpe. 1983. Sensitive colorimetric assay for angiotensin converting enzyme in serum. Clin. Chem. 29:1399-1403.
44. Marre, M., J.P. Claudel, P. Ciret, N. Luis, L. Suarez, and P. Passa. 1987. Laser immunonephelometry for routine quantification of urinary albumin excretion. Clin. Chem. 33:209-213.
45. Bouhanick, B., G. Berrut, A.M. Chameau, M. Hallab, F. Bled, B. Chevet, J. Vergely, V. Rohmer, P. Fressinaud, and M. Marre. 1992. Predictive value of testing random urine sample to detect microalbuminuria in diabetic subjects during outpatient visits. Diabete Metab. 18:54-58.
46. Fabiny, D.L., and G. Ertingshausen. 1971. Automated reaction-rate-method for determination of serum creatinine with the Centrichem. Clin. Chem. 17:696-700.
47. 2. In Statistical Methods in Medical Research. 2nd ed. Blackwell Scientific Publications Oxford 371-380.
48. Armitage, P., and G. Berry. 1990. Attributable risk. In Statistical Methods in Medical Research. 2nd ed. Blackwell Scientific Publications, Oxford. 469-472.
49. Brenner, B.M. 1983. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 23:647-655.
50. Williamson, J.R., K. Chang, M. Frangos, K.S. Hasan, Y. Ido, F. Kawamura, J.R. Nyengaard, M. Van Den Enden, C. Kilo, and R.G. Tilton. 1993. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 42:801-813.
51. Vane, G.R. 1972. Sites of conversion of angiotensin I. In Hypertension. J. Genest and E. Koine, editors. Springer-Verlag New York Inc., New York. 523-532.
52. Alhenc-Gelas, F., T. Baussant, C. Hubert, F. Soubrier, and P. Corvol. 1989. The angiotensin I converting enzyme in the kidney. J. Hypertens. 7:S9-S13.
53. Erdos, E.G. 1990. Angiotensin I-converting enzyme and the changes in our concepts through the years. Hypertension (Dallas). 16:363-370.
54. Jaffa, A.A., P.F. Rust, and R.K. Mayfield. 1995. Kinin, a mediator of diabetes - induced glomerular hyperfiltration. Diabetes. 44:156-160.
55. Parving, H.H., E. Hommel, E. Mathiesen, P. Skott, B. Edsberg, M. Bahnsen, M. Lauritzen, P. Hougaard, and E. Lauritzen. 1988. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes. BMJ (Br. Med. J.). 296:156-160.
56. The EURODIAB IDDM Complications Study Group. 1994. Microvascular and acute complications in IDDM subjects: the EURODIAB IDDM Complications Study. Diabetologia. 37:278-285.
57. Kofoed-Enevoldsen, A., K. Borch-Johnsen, S. Kreiner, J. Nerup, and T. Deckert. 1987. Declining incidence of persistent proteinuria in type 1 (insulin-dependent) diabetic patients in Denmark. Diabetes. 36:205-209.
58. Borch-Johnsen, K., K. Norgaard, E. Hommel, E.R. Mathiesen, J.S. Jensen, T. Deckert, and H.H. Parving. 1992. Is diabetic nephropathy an inherited complication? Kidney Int. 41:719-722.
59. Quinn, M., M.C. Angelico, J.H. Warram, and A.S. Krolewski. 1996. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 39:940-945.
60. Chase, H.P., S.K. Garg, G. Marshall, C.L. Berg, S. Harris, W.E. Jackson, and R.E. Hamman. 1991. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA (J. Am. Med. Assoc.). 265:614-617.
61. Tarnow, L., F. Cambien, P. Rossing, F.S. Nielsen, B.V. Hansen, L. Lecerf, O. Poirier, S. Danilov, S. Boelskifte, K. Borch-Johnsen, and H.H. Parving. 1995. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia. 38:798-803.
62. Lieberman, J., and A. Sastre. 1980. Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann. Intern. Med. 93:825-826.
63. Hallab, M., F. Bled, J.M. Ebran, S. Suraniti, A. Girault, P. Fressinaud, and M. Marre. 1992. Elevated serum angiotensin I converting enzyme activity in type I, insulin-dependent diabetic subjects with persistent microalbuminuria. Acta Diabetologica. 29:82-85.
64. Marre, M., G. Chatellier, H. Leblanc, T.T. Guyenne, J. Menard, and P. Passa. 1988. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ (Br. Med. J.). 297:1092-1095.
65. Hallab, M., Y. Gallois, G. Chatellier, V. Rohmer, P. Fressinaud, and M. Marre. 1993. Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes. BMJ (Br. Med. J.). 306:175-182.
66. Lewis, E.J., L.G. Hunsiker, R.P. Bain, and R.D. Rohde. 1993. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329:1456-1462.
67. Harden, P.N., C. Geddes, P.A. Rowe, J.H. Mcllroy, M. Boulton-Jones, R.S.C. Rodger, B.J.R. Junor, J.D. Briggs, J.M.C. Connell, and A.G. Jardine. 1995. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet. 345:1540-1542.
68. Yoshida, H., T. Mitarai, T. Kawamura, T. Kitajima, Y. Miyasaki, R. Nagasawa, Y. Kawaguchi, H. Kubo, I. Ichikawa, and O. Sakai. 1995. Role of the deletion polymorphism of the angiotensin-converting-enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J. Clin. Invest. 96: 2162-2169.
69. Van Essen, G.G., P.L. Rensma, D. de Zeeuw, W.J. Sluiter, H. Scheffer, A.J. Apperloo, and P.E. de Jong. 1996. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet. 347:94-95.
70. Hannedouche, T., P. Landais , B. Goldfard, N. El Esper, A. Fournier, M. Godin, D. Durand, J. Chanard, F. Mignon, J.M. Suc, et al. 1994. Randomised controlled trial of enalapril and β blockers in non-diabetic chronic renal failure. BMJ (Br. Med. J.). 309:833-837.
71. Mashio, G., D. Alberti, G. Janin, F. Locatelli, J.F.E. Mann, M. Motolese, C. Ponticelli, E. Ritz, P. Ziuchelli, and the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. 1996. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N. Engl. J. Med. 334:939-945.
72. Tarnow, L., F. Cambien, P. Rossing, F.S. Nielsen, B.V. Hansen, S. Ricard, O. Poirier, and H.H. Parving. 1996. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes. 45:367-369.
73. Doria, A., T. Onuma, G. Gearin, M.B.S. Freire, J.H. Warram, and A.S. Krolewski. 1996. Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension. 27:1134-1139.
74. Fogarty, D.G., J.C. Harron, A.E. Hughes, N.C. Nevin, C.C. Doherty, and A.P. Maxwell. 1996. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes. 45:1204-1208.
75. Viberti, G.C., H. Keen, and M.J. Wiseman. 1987. Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. BMJ (Br. Med. J.). 295:515-517.
76. Christlieb, A.R., H.U. Janka, B. Kraus, R.E. Gleason, E.A. Icasas-Cabral, L.M. Aiello, B.V. Cabral, and A. Solano. 1976. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes. 25:268-274.
77. Ballerman, B., K.L. Skorecki, and B.M. Brenner. 1984. Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat. Am. J. Physiol. 247:F110-F116.
78. Rossing, P., L. Tarnow, F.S. Nielsen, S. Boelskifte, B.M. Brenner, and H.H. Parving. 1995. Short stature and diabetic nephropathy. BMJ (Br. Med. J.). 310:296-297.